Andrea Corcoran - Jan 31, 2022 Form 4 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Role: Chief Financial Officer, Executive Vice President, Legal and Secretary
Signature: /s/ Andrea Corcoran
Stock symbol: AVIR
Transactions as of: Jan 31, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/2/2022, 04:15 PM
Next filing: Feb 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AVIR	Stock Option (Right to Buy)	Award	$0	+181K		$0.00	181K	Jan 31, 2022	Common Stock	181K	$7.14	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2022.

Remarks:

Chief Financial Officer, Executive Vice President, Legal and Secretary